UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial

Scientific reports, 2022-07, Vol.12 (1), p.12312-11, Article 12312

2022

Volltextzugriff (PDF)

Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies

mAbs, 2010-05, Vol.2 (3), p.233-255

2010

Volltextzugriff (PDF)

Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro

Molecular and Cellular Biology, 2003-02, Vol.23 (3), p.1034-1043

2003

Volltextzugriff (PDF)

A Cytopathogenic, Apoptosis-Inducing Variant of Hepatitis A Virus

Journal of Virology, 1998-04, Vol.72 (4), p.3370-3376

1998

Volltextzugriff (PDF)

ASEAN and the EC: Labour Costs and Structural Change in the European Community

Manfred Kaiser, Heinz Werner Frings

2018

Volltextzugriff (PDF)

Experimental hepatitis A virus infection in guinea pigs

Journal of medical virology, 2001-08, Vol.64 (4), p.402-409

2001

Volltextzugriff (PDF)

A phase I dose escalation (DE) and cohort expansion (CE) study of ERY974, an anti-glypican 3 (GPC3)/CD3 bispecific antibody, in patients with advanced solid tumors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS3112-TPS3112

2017

Volltextzugriff (PDF)

Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect

FEBS letters, 2002-08, Vol.526 (1), p.93-96

2002

Volltextzugriff (PDF)

Abstract DDT01-05: First-in-class T cell-redirecting bispecific antibody targeting glypican-3: a highly tumor-selective antigen

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.DDT01-05-DDT01-05

2016

Volltextzugriff (PDF)

A phase I dose escalation and cohort expansion study of T-cell redirecting bispecific antibody against Glypican 3 in patients with advanced solid tumors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS2592-TPS2592

2016

Volltextzugriff (PDF)

Effects of SA237, a humanized anti‐interleukin‐6 receptor monoclonal antibody, on pre‐ and postnatal development in cynomolgus monkey

Birth defects research, 2017-07, Vol.109 (11), p.843-856

2017

Volltextzugriff (PDF)

Immunotoxicity testing in nonhuman primates

Methods in molecular biology (Clifton, N.J.), 2010, Vol.598, p.341

2010

Volltextzugriff (PDF)

ASEAN and the EC: Labour Costs and Structural Change in the European Community

1, 1989

Volltextzugriff (PDF)

Adaptation of primate cell-adapted hepatitis A virus strain HM175 to growth in guinea pig cells is independent of mutations in the 5' nontranslated region

Journal of general virology, 2001-03, Vol.82 (3), p.597-602

2001

Volltextzugriff (PDF)

IL-21 Improves Rituximab-Mediated B Cell Depletion

Blood, 2005-11, Vol.106 (11), p.345-345

2005

Volltextzugriff (PDF)

Immunological Profile and Safety Evaluation in a 23-Week Single Dose Study in Cynomolgus Monkey with CHIR-12.12, a Fully Human Antagonist Anti-CD40 Antibody

Blood, 2004-11, Vol.104 (11), p.4638-4638

2004

Volltextzugriff (PDF)

Safety Evaluation of an Fully Human Antagonist Anti-CD40 Antibody, CHIR-12.12, in a Dose Range-Finding Study in Cynomolgus Monkeys

Blood, 2004-11, Vol.104 (11), p.3282-3282

2004

Volltextzugriff (PDF)

Transfer of the cytidine deaminase cDNA into hematopoietic cells

Leukemia research, 1999-11, Vol.23 (11), p.1047-1053

1999

Volltextzugriff (PDF)

Chapter 21 - Study Design Considerations, Technical Procedural Aspects, Scheduling, and Dosing Sampling Volumes

The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment, 2015, p.405-416

2015

Volltextzugriff (PDF)

Nonhuman Primates, Immunotoxicity Assessment of (Bio)Pharmaceuticals in

Encyclopedia of Immunotoxicology, 2016, p.665-667

2016

Volltextzugriff (PDF)

Labour Cost and Output in Manufacturing

ASEAN and the EC, 2018, p.89-119

2018

Volltextzugriff (PDF)

Frontmatter

ASEAN and the EC, 2018, p.i-iv

2018

Volltextzugriff (PDF)

Unemployment, Employment Schemes and Labour Cost Implications

ASEAN and the EC, 2018, p.120-132

2018

Volltextzugriff (PDF)

Concepts, Approaches, Typologies

ASEAN and the EC, 2018, p.3-17

2018

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(172)

Publikationsform

Buchkapitel
(124)
Artikel
(42)
Bücher
(13)
Reviews
(1)

Sprache

Deutsch
(105)
Englisch
(77)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trial

Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies

Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro

An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors

A Cytopathogenic, Apoptosis-Inducing Variant of Hepatitis A Virus

ASEAN and the EC: Labour Costs and Structural Change in the European Community

Experimental hepatitis A virus infection in guinea pigs

A phase I dose escalation (DE) and cohort expansion (CE) study of ERY974, an anti-glypican 3 (GPC3)/CD3 bispecific antibody, in patients with advanced solid tumors

Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect

Abstract DDT01-05: First-in-class T cell-redirecting bispecific antibody targeting glypican-3: a highly tumor-selective antigen

A phase I dose escalation and cohort expansion study of T-cell redirecting bispecific antibody against Glypican 3 in patients with advanced solid tumors

Effects of SA237, a humanized anti‐interleukin‐6 receptor monoclonal antibody, on pre‐ and postnatal development in cynomolgus monkey

Immunotoxicity testing in nonhuman primates

ASEAN and the EC: Labour Costs and Structural Change in the European Community

Adaptation of primate cell-adapted hepatitis A virus strain HM175 to growth in guinea pig cells is independent of mutations in the 5' nontranslated region

IL-21 Improves Rituximab-Mediated B Cell Depletion

Immunological Profile and Safety Evaluation in a 23-Week Single Dose Study in Cynomolgus Monkey with CHIR-12.12, a Fully Human Antagonist Anti-CD40 Antibody

Safety Evaluation of an Fully Human Antagonist Anti-CD40 Antibody, CHIR-12.12, in a Dose Range-Finding Study in Cynomolgus Monkeys

Transfer of the cytidine deaminase cDNA into hematopoietic cells

Chapter 21 - Study Design Considerations, Technical Procedural Aspects, Scheduling, and Dosing Sampling Volumes

Nonhuman Primates, Immunotoxicity Assessment of (Bio)Pharmaceuticals in

Labour Cost and Output in Manufacturing

Frontmatter

Unemployment, Employment Schemes and Labour Cost Implications

Concepts, Approaches, Typologies

Suchergebnisse filtern